Eisai Korea Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Eisai Korea Inc.
RECRUITINGNCT06810960
A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease
The primary purpose of this study is to evaluate safety of lecanemab in the real-world clinical setting as reported by events of amyloid-related imaging abnormalities (ARIA)-edema...
Sponsor: Eisai Korea Inc.Enrolling: 30001 location
Alzheimer's Disease
RECRUITINGNCT06246123
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
The purpose of this study is to collect and evaluate the following information in relation to the safety and the efficacy of Jyseleca tablet (Filgotinib Maleate) 100 milligram...
Sponsor: Eisai Korea Inc.Enrolling: 204020 locations
Arthritis, RheumatoidColitis, Ulcerative